SOX11 hypermethylation as a tumor biomarker in endometrial cancer.

SOX11 hypermethylation as a tumor biomarker in endometrial cancer. Biochimie. 2019 Mar 29;: Authors: Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW PMID: 30935961 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30935961?dopt=Abstract

Source: Biochimie - March 28, 2019 Category: Biochemistry Authors: Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW Tags: Biochimie Source Type: research

More News: Biochemistry | Cancer | Cancer & Oncology | Endometrial Cancer